Endothelium-derived endothelin-1 mediates sickle cell nephropathy
Function · 2026-04-01 · 7 (2)
DOI: 10.1152/function.001.2026 ↗At a glance
Multizentrische Studie in Function, published on 2026-04-01. Written by Malgorzata Kasztan and 6 co-authors. Institution: Section of Cardio Renal Physiology & Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alaba…. Major MEDLINE topics: Endothelin-1, Anemia, Sickle Cell, Kidney Diseases. Cited 2 times so far (Crossref); 61 references. The full text is freely available in PubMed Central. Funded by: NIDDK NIH HHS, NIH HHS, NHLBI NIH HHS.
Abstract (original language)
Sickle cell nephropathy (SCN) significantly shortens the life expectancy of patients with sickle cell disease (SCD). We previously reported that endothelin-1 (ET-1) and endothelin A receptor (ET A ) are upregulated in SCN, and ET A antagonism mitigates SCN early in the disease progression in a humanized mouse model of SCD. We hypothesized that endothelium-derived ET-1 mediates the progression of SCN and T cell inflammation in the kidney of SCD mice. To test this hypothesis, we first used allogenic bone marrow transplantation from humanized sickle cell mice (HbSS) into endothelial-derived ET-1 knockout (VEET KO) mice, revealing that endothelial-derived ET-1 mitigates SCN and regulates the renal inflammatory response and T cell infiltration. Second, using young (4–5 mo old) and middle-aged (10–15 mo old) HbSS mice lacking endothelial-specific ET-1 (HbSS-VEET KO), we found a temporal maintenance of glomerular filtration rate, reduced infiltration of T cells to the kidney, and reduced progression of SCN. Furthermore, 2-wk ET A antagonism in middle-aged HbSS mice reduced infiltration of T cells. Finally, flow cytometric analyses revealed blunting of kidney T helper 17 (T H 17) cells without a change in kidney T regulatory cells in HbSS-VEET KO mice, suggesting T cell subset-specific regulation by endothelial-derived ET-1 signaling. In vitro studies showed that ET A antagonism directly inhibits T H 17 polarization and IL-17A production, suggesting that in established sickle cell disease, the ET A receptor-T H 17 cell axis may play a key role in maintenance of fibrosis in SCN. Taken together, these data indicate that endothelial-derived ET-1 mediates the progression of SCN and strengthens the rationale for targeting ET-1 signaling as a new therapeutic approach.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Section of Cardio Renal Physiology & Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.
- Division of Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, United States.
- Blood Research Center, Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.
ORCID profiles: Jennifer S Pollock
Funding
- NIDDK NIH HHS
- NIH HHS
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Cite
APA
Kasztan, M., Molina, P. A., Fox, B. M., Saurage, E., Colson, J. C., Pollock, D. M., & Pollock, J. S. (2026). Endothelium-derived endothelin-1 mediates sickle cell nephropathy. Function, 7(2). https://doi.org/10.1152/function.001.2026
Vancouver
Kasztan M, Molina PA, Fox BM, Saurage E, Colson JC, Pollock DM, et al. Endothelium-derived endothelin-1 mediates sickle cell nephropathy. Function. 2026;7(2). doi:10.1152/function.001.2026
BibTeX
@article{Kasztan2026,
author = {Kasztan, Malgorzata and Molina, Patrick A and Fox, Brandon M and Saurage, Elizabeth and Colson, Jackson C and Pollock, David M and Pollock, Jennifer S},
title = {Endothelium-derived endothelin-1 mediates sickle cell nephropathy},
journal = {Function},
year = {2026},
volume = {7},
number = {2},
doi = {10.1152/function.001.2026}
}
EUVIMED